XML 37 R25.htm IDEA: XBRL DOCUMENT
v3.26.1

Research Collaboration and License Agreements (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Research Collaboration And License Agreements [Abstract] |
Summary of Sources of Revenue | During the three months ended March 31, 2026 and 2025, the Company's sources of revenue were as follows:
(dollars in millions) | March 31, 2026 |  | March 31, 2025
Revenue |  |  |
Vepdegestrant (ARV-471) Collaboration Agreement | $ | 14.4 |  |  | $ | 189.9 |
Pfizer Research Collaboration Agreement | 1.2 |  |  | (1.1) |
Total Revenue | $ | 15.6 |  |  | $ | 188.8 |
Schedule of Contract Balances | Changes in the Company's contract balances for the three months ended March 31, 2026 and 2025 were as follows:
(dollars in millions) | March 31, 2026 |  | March 31, 2025
Accounts receivable related to collaborations |  |  |
Beginning balance | $ | 1.0 |  |  | $ | 5.7 |
Additions | 0.8 |  |  | — |
Payments received | — |  |  | (5.3) |
Ending balance | $ | 1.8 |  |  | $ | 0.4 |
Accounts payable related to collaborations |  |  |
Beginning balance | $ | 16.8 |  |  | $ | 5.4 |
Additions | 9.1 |  |  | 19.4 |
Payments made | — |  |  | (5.4) |
Ending balance | $ | 25.9 |  |  | $ | 19.4 |
Contract assets: Collaboration contract asset |  |  |
Beginning balance | $ | 3.5 |  |  | $ | 7.8 |
Amortization | (0.3) |  |  | (3.3) |
Ending balance | $ | 3.2 |  |  | $ | 4.5 |
Contract liabilities: Deferred revenue |  |  |
Beginning balance | $ | 205.6 |  |  | $ | 448.2 |
Revenue recognized from balances held at the beginning of the period | (15.6) |  |  | (188.8) |
Ending balance | $ | 190.0 |  |  | $ | 259.4 |
Schedule of Transaction Price Allocated to Performance Obligations | The aggregate amount of the transaction price allocated to performance obligations that were unsatisfied as of March 31, 2026 totaled $190.0 million, which is expected to be recognized in the following periods:
(dollars in millions) |
Remainder of 2026 | $ | 46.7 |
2027 | 20.3 |
2028 | 20.3 |
2029 | 102.7 |
Total | $ | 190.0 |

X
- Definition Research Collaboration And License Agreements + References No definition available. + Details
Name: | arvn_ResearchCollaborationAndLicenseAgreementsAbstract
Namespace Prefix: | arvn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of expected timing for satisfying remaining performance obligation. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b)(1) -SubTopic 10 -Topic 606 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13 + Details
Name: | us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration